Chan Ye Xin Xi Wang·2025-10-29 01:24Core Insights - The Chinese artificial bioactive bone industry is experiencing rapid growth, with a market size projected to reach approximately 1.528 billion yuan in 2024, reflecting a year-on-year increase of 6.26% [1][4] - This growth is primarily driven by an aging population, rising incidence of orthopedic diseases, and advancements in medical technology [1][4] - Domestic companies have made significant progress in the research and production of artificial bioactive bones, with products like "Yougou Sheng®" from Asia Bio covering thousands of hospitals across 31 provinces in China by 2024 [1][4] Industry Overview - Artificial bioactive bone is a type of bone-like material created through bioengineering or materials science, characterized by its ability to chemically bond with surrounding living bone tissue, promoting bone regeneration and defect repair [2] - The industry has evolved from traditional artificial bones, which lack bioactivity, to bioactive materials that significantly enhance bone repair efficiency and integration [2] Industry Development History - The Chinese artificial bioactive bone industry began in 2009 and has gone through three development phases, with significant milestones including the establishment of GMP production lines and the introduction of 3D printing technology [3][4] - By 2021, Asia Bio's "Yougou Sheng" received NMPA registration, becoming the first active multi-level structure artificial bone in China, and was included in the medical insurance catalog of 23 provinces [3][4] Market Size - The market for artificial bioactive bones in China is expected to grow to approximately 1.528 billion yuan in 2024, driven by demographic changes and advancements in medical technology [1][4] Key Companies - Major players in the industry include Aojing Medical, Zhenghai Bio, and Asia Bio, which are rapidly emerging through technological innovations and competitive pricing strategies [5][6] - Zhenghai Bio's "Haiyu" product has achieved a clinical fusion rate of 100% and is included in the medical insurance catalog of 23 provinces [5][6] - Aojing Medical has expanded its production capacity and is advancing into the dental implant sector through acquisitions [8][9] Industry Development Trends 1. Continuous technological innovation is expected to drive product upgrades, with advancements in 3D printing and nanotechnology enhancing the performance of bioactive bones [10] 2. Policy and market dynamics are anticipated to accelerate industry growth, with government initiatives promoting the adoption of cost-effective domestic products [11] 3. The industry is shifting towards a global presence, with companies expanding through international collaborations and acquisitions, aiming to establish a robust global market footprint [12][13]